清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer

医学 脂肪性肝炎 氧化应激 药理学 脂肪肝 肝硬化 肝细胞癌 血管生成 肝再生 肝细胞 癌症研究 肝癌 癌症 肝损伤 内科学 再生(生物学) 化学 生物 体外 生物化学 疾病 细胞生物学
作者
János Fehér,Gabriella Lengyel
出处
期刊:Current Pharmaceutical Biotechnology [Bentham Science]
卷期号:13 (1): 210-217 被引量:213
标识
DOI:10.2174/138920112798868818
摘要

In chronic liver diseases caused by oxidative stress (alcoholic and non-alcoholic fatty liver diseases, drug- and chemical-induced hepatic toxicity), the antioxidant medicines such as silymarin can have beneficial effect. Liver cirrhosis, non-alcoholic fatty liver and steatohepatitis are risk factors for hepatocellular carcinoma (HCC). Insulin resistance and oxidative stress are the major pathogenetic mechanisms leading the hepatic cell injury in these patients. The silymarin exerts membrane-stabilizing and antioxidant activity, it promotes hepatocyte regeneration; furthermore it reduces the inflammatory reaction, and inhibits the fibrogenesis in the liver. These results have been established by experimental and clinical trials. According to open studies the long-term administration of silymarin significantly increased survival time of patients with alcohol induced liver cirrhosis. Based on the results of studies using methods of molecular biology, silymarin can significantly reduce tumor cell proliferation, angiogenesis as well as insulin resistance. Furthermore, it exerts an anti-atherosclerotic effect, and suppresses tumor necrosis factor-alpha-induced protein production and mRNA expression due to adhesion molecules. The chemopreventive effect of silymarin on HCC has been established in several studies using in vitro and in vivo methods; it can exert a beneficial effect on the balance of cell survival and apoptosis by interfering cytokines. In addition to this, anti-inflammatory activity and inhibitory effect of silymarin on the development of metastases have also been detected. In some neoplastic diseases silymarin can be administered as adjuvant therapy as well. Keywords: Cancer prevention, chronic liver diseases, hepatitis B virus, hepatitis C virus, hepatocellular carcinoma, silymarin, steatohepatitis, oxidative stress, Liver cirrhosis, membrane-stabilizing, insulin resistance, metastases, adjuvant therapy, hepatobiliary diseases

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
充电宝应助凉宫八月采纳,获得10
14秒前
14秒前
独特的鹅完成签到,获得积分10
18秒前
Sinan117完成签到,获得积分10
27秒前
蝎子莱莱xth完成签到,获得积分10
29秒前
29秒前
32秒前
凉宫八月发布了新的文献求助10
34秒前
氢锂钠钾铷铯钫完成签到,获得积分10
36秒前
牛马完成签到 ,获得积分10
39秒前
Square完成签到,获得积分10
39秒前
领导范儿应助科研通管家采纳,获得10
46秒前
Rouadou完成签到,获得积分10
47秒前
48秒前
wanci应助gs采纳,获得10
48秒前
无情的琳发布了新的文献求助10
51秒前
57秒前
我要发一区完成签到 ,获得积分10
59秒前
gs发布了新的文献求助10
1分钟前
John完成签到 ,获得积分10
1分钟前
1分钟前
gs完成签到,获得积分10
1分钟前
无情的琳发布了新的文献求助10
1分钟前
无情的琳发布了新的文献求助10
1分钟前
1分钟前
123完成签到,获得积分10
1分钟前
滕祥给滕祥的求助进行了留言
1分钟前
1分钟前
1分钟前
YVO4发布了新的文献求助10
1分钟前
1分钟前
燃烧的皮皮虾完成签到,获得积分10
2分钟前
滕祥驳回了hanlin应助
2分钟前
orixero应助无情的琳采纳,获得10
2分钟前
YVO4完成签到,获得积分10
2分钟前
2分钟前
丘比特应助凉宫八月采纳,获得10
2分钟前
2分钟前
无情的琳发布了新的文献求助10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5724216
求助须知:如何正确求助?哪些是违规求助? 5285755
关于积分的说明 15299702
捐赠科研通 4872263
什么是DOI,文献DOI怎么找? 2616807
邀请新用户注册赠送积分活动 1566632
关于科研通互助平台的介绍 1523573